Sort
21,453 grants matching “tuberculosis”
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
$13,655,252Michael David Hughes · Harvard School Of Public Health · UM1 · FY2016 · AI
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
$13,641,027Michael David Hughes · Harvard School Of Public Health · UM1 · FY2017 · AI
Broad Institute Comprehensive Screening Center
$13,609,814Stuart L Schreiber · Massachusetts Institute Of Technology · U54 · FY2008 · HG
National Emerging Infectious Diseases Laboratories Operations
$13,568,475Ronald B Corley · Boston University Medical Campus · UC7 · FY2014 · AI
IMPAACT Leadership Group
$13,535,130Sharon A Nachman · Johns Hopkins University · UM1 · FY2025 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
$13,471,730Kevin Urdahl · Seattle Children'S Hospital · N01 · FY2019 · AI
SDMC: HIV Vaccine Trials Network
$13,241,799Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2015 · AI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$13,210,979Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2010 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
$13,001,420Kevin Urdahl · Seattle Children'S Hospital · N01 · FY2021 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
$12,955,056Rhea Coler · Seattle Children'S Hospital · N01 · FY2023 · AI
SDMC - IMPAACT Leadership Group
$12,856,979David Eric Shapiro · Harvard University D/B/A Harvard School Of Public Health · UM1 · FY2024 · AI
Regulatory Support Services
$12,854,530John Tierney · National Institute Of Allergy And Infectious Diseases · ZID · FY2024 · AI
Core D: Medicinal Chemistry Core
$12,760,250Timothy M Willson · Univ Of North Carolina Chapel Hill · U19 · FY2022 · AI
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
$12,701,831Michael David Hughes · Harvard School Of Public Health · UM1 · FY2014 · AI
National Emerging Infectious Diseases Laboratories Operations
$12,697,405Ronald B Corley · Boston University Medical Campus · UC7 · FY2015 · AI
SDMC - IMPAACT Leadership Group
$12,235,847David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2021 · AI
SDMC - IMPAACT Leadership Group
$12,080,586David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2023 · AI
NIAID Global Collaborative for TB Research and Development
$12,000,000Chris Maxwell · National Institute Of Allergy And Infectious Diseases · Y01 · FY2022 · AI
SDMC - IMPAACT Leadership Group
$11,719,650David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2022 · AI
Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)
$11,546,233Rhea Coler · Seattle Children'S Hospital · N01 · FY2024 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)
$11,541,977Kevin Urdahl · Seattle Children'S Hospital · N01 · FY2020 · AI
Regulatory Support Services
$11,311,037Jerome Pierson · National Institute Of Allergy And Infectious Diseases · ZID · FY2017 · AI
Regulatory Support Services
$11,269,404Jerome Pierson · National Institute Of Allergy And Infectious Diseases · ZID · FY2019 · AI
HIV Vaccine Trials Network Laboratory Center
$11,222,643Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
COVID-19 Supplement #3 Moderna Trial
$11,154,495Daniel F. Hoft · Saint Louis University · UM1 · FY2020 · AI